Anxiety News and Research

Latest Anxiety News and Research

Notre Dame, Madison Center collaborate to research on mental health therapies

Daniel Lapsley, Ph.D., Chairman of the Department of Psychology for Notre Dame University, gives a significant amount of credit to Madison Center, Indiana's largest community mental health agency, for Notre Dame's coup in recruiting two world-class researchers. Now Notre Dame and Madison Center have created a partnership to collaborate on research that is designed to improve treatment and therapies for mental health patients.

12 Aug 2010

Increased brain activity predicts anxious temperament in young primates

A new study focused on anxiety and brain activity pinpoints the brain regions that are relevant to developing childhood anxiety. The findings, published in the Aug. 12 edition of the journal Nature, may lead to new strategies for early detection and treatment of at-risk children.

12 Aug 2010

Mental health bill for 2008 was $5.3 billion: Report

According to the Australian Institute of Health and Welfare (AIHW), the country is spending more and more to deal with its mental ailment burden. This emerged from a report from the AIHW saying that finances spent on mental health services between 2007 to 2008 were $5.3 billion. Of this around 60 per cent came from state and territory governments, 36 per cent from the Commonwealth, and the rest from private health funds.

11 Aug 2010

Labopharm launches antidepressant OLEPTRO for major depressive disorder in U.S.

Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, has been launched in the United States by its joint venture with Gruppo Angelini, Angelini Labopharm. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established in a trial of outpatients with MDD as well as in trials with the immediate release formulation of trazodone.

11 Aug 2010

SAMHSA survey highlights extent of underage alcohol consumption

A new report released by the Substance Abuse and Mental Health Services Administration (SAMHSA) highlights the extent of the underage drinking problem in the nation through the lens of alcohol-related emergency department visits involving adolescents and young adults aged 12 to 20.

10 Aug 2010

Older Americans suffer from full-blown depression: Report

Maureen Duffy's memories of her grandmother are cloudy. Not because of time, but by a condition that cast a shadow over the woman Duffy had visited as a child.

10 Aug 2010

Texas Children's Hospital provides tips to ensure healthy and successful school year

It's August and for many families that means it's time to head back to school. From sleep schedules, nutrition, immunizations, heart health, heat illnesses and more, Texas Children's Hospital in Houston provides parents with tips to ensure their children have a safe, healthy and successful school year.

10 Aug 2010

Elan and Transition Therapeutics report results of ELND005 Phase 2 study for Alzheimer's disease

Elan Corporation, plc and Transition Therapeutics, Inc today announced the results of a Phase 2 placebo-controlled study in 351 patients with mild to moderate Alzheimer's disease who received study drug for up to 18 months (Study AD201). Study subjects with MMSE scores between 16 and 26 received ELND005 oral doses of 250 mg, 1000 mg or 2000 mg twice daily or matching placebo. The study's cognitive (NTB) and functional (ADCS-ADL) co - primary endpoints did not achieve statistical significance.

10 Aug 2010

Study finds selective serotonin reuptake inhibitors not beneficial for autistic children

Antidepressants commonly prescribed to people with autistic spectrum disorders cannot be recommended based on current evidence, a new study by Cochrane Researchers concludes. Despite some evidence of benefits in adults diagnosed with autism, they say there is no evidence for any benefits associated with selective serotonin reuptake inhibitors (SSRIs) in children, who may suffer serious adverse effects as a result of taking the drugs.

9 Aug 2010

Antidepressants cannot be recommended in children with autism: Study

According to a thorough review published by Cochrane Researchers, commonly prescribed antidepressant drugs cannot be recommended for those suffering from autistic spectrum disorders based on current evidence. They say that there may be benefits of antidepressants in adults diagnosed with autism but similar benefits are not seen in children. These children may suffer extremely adverse effects if they consume selective serotonin reuptake inhibitors (SSRIs).

8 Aug 2010

Asynchronous telepsychiatry provides primary-care physicians greater access to psychiatric consultation

A new study by researchers at the UC Davis School of Medicine has found that psychiatrists can accurately assess a patient's mental health by viewing videotaped interviews that are sent to them for consultation and treatment recommendations.

7 Aug 2010

Drugs that reduce activity of ABDH6 enzyme can prevent brain damage: Study

A newly discovered molecular mechanism helps control the amount and effectiveness of a substance that mimics an active ingredient in marijuana, but that is produced by the body's own nerve cells.

7 Aug 2010

Vyvanse Capsules CII demonstrates significant improvement in adults with ADHD: Phase 3b study

Shire plc, the global specialty biopharmaceutical company, today announced that a Phase 3b study published in Behavioral and Brain Functions found adults with Attention Deficit Hyperactivity Disorder who took once-daily Vyvanse (lisdexamfetamine dimesylate) Capsules CII demonstrated significant improvement in attention.

6 Aug 2010

TEMPO study recommends early administration of Azilect in PD patients

Teva Pharmaceutical Industries Ltd. and H. Lundbeck A/S (Lundbeck) today announced newly published long-term data on Azilect(rasagiline tablets) from the TEMPO study and its open-label extension. The findings confirm the long-term efficacy, safety and tolerability of Azilect® in patients with Parkinson's disease (PD) and further demonstrate the benefits obtained with early treatment initiation. The data was published in the June 2010 issue of the International Journal of Neuroscience.

6 Aug 2010

House to return after Senate approves extension of enhanced Medicaid funds

House Speaker Nancy Pelosi will bring the House back from its recess next week to vote on an extension of enhanced state Medicaid funds the Senate is poised to approve as soon as Thursday afternoon, Politico reports.

6 Aug 2010

Free clinic in D.C. draws more than 1,000 patients

With a wounded economy and high unemployment, more than 1,000 people came to a one-day free health clinic in the nation's capital Wednesday to get the basic care they can't afford or are otherwise denied because they have no insurance. More than three-quarters of those attending don't have insurance because they are recently unemployed, work for small businesses, earn hourly wages, or must work multiple part-time jobs with no insurance, said the event's medical director Dr. Bobby Kapur.

6 Aug 2010

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck reported that two pivotal Phase III registration studies for boceprevir, its investigational oral hepatitis C protease inhibitor, have been completed and met the primary endpoints: in both studies in patients with chronic hepatitis C virus (HCV) genotype 1 infection, the addition of boceprevir to treatment with PEGINTRON® and REBETOL® significantly increased the number of patients who achieved sustained virologic response, compared to control groups that received Peg/riba plus placebo.

5 Aug 2010

Healing Touch helps to restore normal energy balance

Greenwich Hospital surgical, labor and delivery, and oncology patients are among those who have received a healing boost through a form of energy therapy known as Healing Touch.The hospital, known for its reputation of service excellence, is among a growing number of medical facilities utilizing Healing Touch, which is a gentle, noninvasive therapy shown to facilitate the relaxation response to enhance the healing process. Research shows that, in addition to inducing a deep sense of calm and relaxation, Healing Touch helps to reduce pain, decrease anxiety, promote sleep and improve an overall sense of well-being.

5 Aug 2010

University of Pennsylvania announces recipients of 2010 Templeton Positive Neuroscience Awards

The Positive Psychology Center of the University of Pennsylvania and the John Templeton Foundation have announced the recipients of the 2010 Templeton Positive Neuroscience Awards, $2.9 million given to 15 new research projects at the intersection of neuroscience and positive psychology.

5 Aug 2010

Mothers of premature babies have high levels of stress and anxiety

The incidence of premature babies has been stable or even increased over time. The phenomenon brings with it the possibility of neurological, sensorial, respiratory, cognitive or psychomotor consequences for the child, both in the short and the medium term. These consequences also are a concern to child psychiatrists and psychologists, as it is currently known that the progress of a premature baby and the appearance or otherwise of problems depend largely on the family environment, above all how the mother interacts with her child in the first months of its life.

5 Aug 2010